Omega-3 and Cardiovascular Risk Factors and Kidney Related Biomarkers
NCT03197220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99
Last updated 2020-04-07
Summary
In this study, 99 overweight or obese women that referred to the Clinic Nutrition to lose weight were randomly divided into three groups according to body mass index (BMI) by random-number table (figure1). We attempted to match all three groups for BMI, probable medications, and age. Subjects were excluded if they had risk factors of cardiovascular diseases or allergic reactions to fish or walnut, or received lowering blood glucose or lipid profile agents. Also, participants with weak economic status could not enter to this study (due to the high cost of fish and walnuts). Before the start of this study, the information in the form of questionnaire about demographic, medical history, and medication use, was completed. Participants were aware about overview of this study, and completed the consent form. The NATIONAL INSTITUTED FOR MEDICAL RESEARCH DEVELOPMENT (NIMAD), approved all procedures involving human subjects. The study has been done in accordance with the ethical standards in declaration of Helsinki.
Then all of the three groups received a low-calorie diet in order to lose weight. The distribution of macronutrients was similar in three groups (carbohydrate 55%, fat 33%, and protein 17%). The amount of different fatty acids (saturated, unsaturated with mono double bond, and polyunsaturated fatty acids) intake in these diets was the same but the sources of omega-3 between these groups were different. In the first group, subjects were instructed to consume 300 gram fatty fish, such as Salmon fish during a week in two separated meals (each meal 150 gr fatty fish) and to avoid consumption of plant sources of omega-3 (soybean oil, canola, flaxseed and walnuts). In the second group, subjects were asked to consume walnuts three times a week and each time two walnuts (totally 18 walnuts/wk) and avoid the consumption of fish. And in the third group, subjects were recommended to consume 150 g fatty fish during a week and nine walnuts. The amount of omega-3 fatty acids considered in this study covered the typical recommended intake (0.3 to 0.5 g/d of EPA+DHA and 0.8 to 1.1 g/d of ALA)(14). Dietary intakes of all patients were controlled by a dietitian and they were followed for 12 weeks. Dietary intakes were assessed by three dietary records (one weekend and two week days).
Conditions
- Cardiovascular Risk Factor and Kidney Related Biomarkers
Interventions
- OTHER
-
fish
300 gr/week fish
- OTHER
-
walnut
18 walnut per week
- OTHER
-
fish-walnut
150 gr fish and 9 walnut per week
Sponsors & Collaborators
-
Isfahan University of Medical Sciences
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-11-22
- Primary Completion
- 2016-11-21
- Completion
- 2017-01-20
More Related Trials
-
Effects of N-3 Intake on Lipid Profile, Biochemical and Inflammatory Markers in Subjects with Obesity
NCT04901052 ·Status: COMPLETED ·Phase: NA
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
Intake of Omega 3 in Morbidly Obese Patients
NCT02113696 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults
NCT02921048 ·Status: COMPLETED
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women
NCT02816125 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Omega-3 Fatty Acids and Insulin Sensitivity
NCT01686568 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
NCT00371982 ·Status: TERMINATED ·Phase: NA
-
Health Beneficial Effects of Krill Oil and Lean and Fatty Fish
NCT02568228 ·Status: COMPLETED ·Phase: NA
-
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
NCT04496154 ·Status: COMPLETED ·Phase: NA
-
Bioavailability of EPA + DHA Enriched Canned Tuna and Its Acute Effects
NCT03742492 ·Status: UNKNOWN ·Phase: PHASE2
-
Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
NCT00114296 ·Status: UNKNOWN ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins
NCT00976872 ·Status: COMPLETED ·Phase: NA
-
Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles
NCT01442480 ·Status: COMPLETED ·Phase: NA
-
A Study of Different Types of Fatty Acid on Risk Factors for Heart Disease
NCT01351324 ·Status: COMPLETED ·Phase: NA
-
Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles
NCT03203512 ·Status: COMPLETED ·Phase: NA
-
Effects of Dietary Polyphenols and ω-3 Fatty Acids on Cardiovascular Risk Factors in High Risk Subjects
NCT01154478 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children
NCT06555705 ·Status: COMPLETED ·Phase: NA
-
Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
NCT02271230 ·Status: COMPLETED ·Phase: PHASE3
-
Oxidized Omega-3 Supplements With Different Oxidation
NCT01799720 ·Status: COMPLETED ·Phase: NA
-
Vascular Impact of Omega-3 in Metabolic Syndrome
NCT01566188 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Consumption on Cardiovascular Risk Factors
NCT03111784 ·Status: COMPLETED ·Phase: NA
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
NCT03372733 ·Status: RECRUITING ·Phase: PHASE2